Patents by Inventor Joseph E. Low

Joseph E. Low has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating inflammation using antibodies to M-CSF
    Patent number: 7108852
    Abstract: A hematopoetic factor called “colony stimulating factor” (CSF) is capable of synergizing the attracting capabilities of chemokines and of inducing the accumulation and/or activation in vitro and in vivo of key components of inflammatory responses. Various types of agents that inhibit or otherwise hinder the production, release or activity of CSF could be used therapeutically in the treatment of ischemia and other inflammatory diseases, such as autoimmune disease, and various chronic inflammatory diseases such as rheumatoid arthritis and psoriasis.
    Type: Grant
    Filed: February 23, 2001
    Date of Patent: September 19, 2006
    Assignee: Warner-Lambert Company LLC
    Inventors: Madhav N. Devalaraja, Joseph E. Low
  • Inhibitors of colony stimulating factors
    Publication number: 20020141994
    Abstract: A hematopoetic factor called “colony stimulating factor” (CSF) is capable of synergizing the attracting capabilities of chemokines and of inducing the accumulation and/or activation in vitro and in vivo of key components of inflammatory responses. Various types of agents that inhibit or otherwise hinder the production, release or activity of CSF could be used therapeutically in the treatment of ischemia and other inflammatory diseases, such as autoimmune disease, and various chronic inflammatory diseases such as rheumatoid arthritis and psoriasis.
    Type: Application
    Filed: February 23, 2001
    Publication date: October 3, 2002
    Inventors: Madhav N. Devalaraja, Joseph E. Low
  • Method of preventing ulcer formation caused by nonsteroidal antiinflammatory drugs employing tetrazol-benzothiophene carboxamide compounds
    Patent number: 5426113
    Abstract: Tetrazol-benzothiophenes carboxamides or a pharmaceutically acceptable salt thereof are useful in preventing ulcer formation caused by nonsteroidal antiinflammatory drugs in mammals.
    Type: Grant
    Filed: April 8, 1994
    Date of Patent: June 20, 1995
    Assignee: Warner-Lambert Company
    Inventor: Joseph E. Low